000			02053 a2200601 4500
005			20250515205255.0
264		0	_c20101012
008			201010s 0 0 eng d
022			_a1651-2006
024	7		_a10.3109/14017430903531008 _2doi
040			_aNLM _beng _cNLM
100	1		_aSvedjeholm, Rolf
245	0	0	_aA metabolic protective strategy could improve long-term survival in patients with LV-dysfunction undergoing CABG. _h[electronic resource]
260			_bScandinavian cardiovascular journal : SCJ _cFeb 2010
300			_a45-58 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAged
650	0	4	_aCardioplegic Solutions _xtherapeutic use
650	0	4	_aCardiopulmonary Bypass
650	0	4	_aCardiotonic Agents _xtherapeutic use
650	0	4	_aCoronary Artery Bypass _xadverse effects
650	0	4	_aEnergy Metabolism
650	0	4	_aFemale
650	0	4	_aGlucose _xtherapeutic use
650	0	4	_aGlutamic Acid _xadministration & dosage
650	0	4	_aHeart Failure _xetiology
650	0	4	_aHumans
650	0	4	_aInsulin _xtherapeutic use
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aLogistic Models
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMyocardial Contraction
650	0	4	_aMyocardial Ischemia _xcomplications
650	0	4	_aMyocardium _xmetabolism
650	0	4	_aOxygen Consumption
650	0	4	_aPotassium _xtherapeutic use
650	0	4	_aRecovery of Function
650	0	4	_aRisk Assessment
650	0	4	_aRisk Factors
650	0	4	_aSeverity of Illness Index
650	0	4	_aStroke Volume
650	0	4	_aSweden
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aVentricular Dysfunction, Left _xcomplications
650	0	4	_aVentricular Function, Left
700	1		_aVidlund, Mårten
700	1		_aVanhanen, Ingemar
700	1		_aHåkanson, Erik
773	0		_tScandinavian cardiovascular journal : SCJ _gvol. 44 _gno. 1 _gp. 45-58
856	4	0	_uhttps://doi.org/10.3109/14017430903531008 _zAvailable from publisher's website
999			_c19512374 _d19512374